Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.

Molecular carcinogenesis·2026
Same author

Workforce growth without reach: National trends in access to high-volume parathyroid surgeons.

Surgery·2026
Same author

Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage.

Endocrine-related cancer·2026
Same author

Utilization of thyroid ultrasound and surgery after glucagon-like peptide-1 receptor agonist prescription.

Surgery·2026
Same author

Dual targeting of BRAF<sup>V600E</sup> and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress.

Journal of experimental & clinical cancer research : CR·2026
Same author

Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990].

Cancer letters·2025

Related Experiment Video

Updated: May 3, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.9K

Multimodal image driven patient specific tumor growth modeling.

Yixun Liu1, Samira M Sadowski2, Allison B Weisbrod2

  • 1Radiology and Imaging Sciences, NIH, USA.

Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention
|February 8, 2014
PubMed
Summary

This study presents a personalized tumor growth model using CT and PET scans. The model accurately predicts tumor size and characteristics, aiding in cancer staging and treatment planning.

More Related Videos

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

20.6K
High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately
08:39

High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately

Published on: July 8, 2014

28.0K

Related Experiment Videos

Last Updated: May 3, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.9K
Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

20.6K
High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately
08:39

High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately

Published on: July 8, 2014

28.0K

Area of Science:

  • Medical Imaging
  • Computational Biology
  • Oncology

Background:

  • Personalized tumor growth models are crucial for accurate cancer staging and therapy planning.
  • Integrating clinical imaging data enhances model specificity and predictive power.

Purpose of the Study:

  • To develop a patient-specific tumor growth model using longitudinal dual-phase CT and FDG-PET imaging.
  • To integrate cancerous cell proliferation, infiltration, metabolic rate, and biomechanical responses into a reaction-advection-diffusion framework.
  • To bridge the model with multimodal radiologic images via intracellular volume fraction (ICVF) and Standardized Uptake Value (SUV).

Main Methods:

  • Construction of a patient-specific tumor growth model using a reaction-advection-diffusion equation.
  • Integration of multimodal radiologic data (CT and FDG-PET) through ICVF and SUV.
  • Validation of the model by comparing predicted tumors against observed tumors in six patients.

Main Results:

  • The model achieved an average surface distance (ASD) of 2.5 +/- 0.7 mm between predicted and reference tumors.
  • Root mean square difference (RMSD) of the ICVF map was 4.3 +/- 0.6%.
  • Average ICVF difference (AICVFD) of the tumor surface was 2.6 +/- 0.8%, and tumor relative volume difference (RVD) was 7.7 +/- 1.9%.

Conclusions:

  • The developed personalized tumor growth model accurately predicts tumor progression using multimodal imaging.
  • The model shows significant potential for improving tumor staging and guiding therapy planning in neuroendocrine tumors.